miR-361 enhances sensitivity to 5-fluorouracil by targeting the FOXM1-ABCC5/10 signaling pathway in colorectal cancer

Colorectal cancer (CRC) is one of most common malignancies worldwide. 5-fluorouracil (5-FU) is a mainstay of CRC treatment, particularly in patients with advanced stages of the disease; however, 5-FU-based chemotherapy is not always effective and may result in progression of the disease. The present...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Luyao, Li, Bo, Zhang, Beilin, Zhang, Hua, Suo, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757261/
https://www.ncbi.nlm.nih.gov/pubmed/31579069
http://dx.doi.org/10.3892/ol.2019.10741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757261/
https://www.ncbi.nlm.nih.gov/pubmed/31579069
http://dx.doi.org/10.3892/ol.2019.10741

Ejemplares similares